Search

In Stock

Buy Olumiant (baricitinib) Online

DISEASE INDICATIONS: Rheumatoid Arthritis

MANUFACTURER: Eli Lilly Nederland B.V.

USAGE: Oral

MEDICINE APPROVED BY: European Medical Agency (EMA)

Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

From $1,070.33

Clear
Compare

Olumiant (baricitinib) is a prescription medication used to treat:

  • Moderately to severely active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (DMARDs).
  • Alopecia areata (AA) in adults with severe AA who are not candidates for other systemic therapies.
  • COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Olumiant is a Janus kinase (JAK) inhibitor. JAKs are enzymes that play a role in the inflammation and immune response. By blocking JAKs, Olumiant can help to reduce inflammation and improve symptoms of RA, AA, and COVID-19.

How to Use

Olumiant is taken orally once a day. The recommended dose for RA is 2 mg or 4 mg. The recommended dose for AA is 4 mg. The recommended dose for COVID-19 is 4 mg.

Important Safety Information

Olumiant can increase the risk of serious infections, including tuberculosis (TB), shingles, and others caused by bacteria, fungi, or viruses. Before starting Olumiant, your doctor will test you for TB. Olumiant can also reactivate latent TB infection.

Olumiant can also increase the risk of other side effects, such as:

  • Allergic reactions
  • Blood clots
  • Cancer
  • High cholesterol
  • High liver enzymes
  • Low blood counts
  • Lymphoma
  • Serious heart problems
  • Stomach problems
  • Stroke

Indications

Olumiant is indicated for the treatment of:

  • Moderately to severely active RA in adults who have responded inadequately to, or who are intolerant to one or more DMARDs.
  • Severe AA in adults who are not candidates for other systemic therapies.
  • COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or ECMO.

Precautions

Olumiant should be used with caution in patients with a history of serious infections, TB, blood clots, cancer, high cholesterol, high liver enzymes, low blood counts, lymphoma, heart problems, or stomach problems.

Olumiant should not be used in patients who have a history of severe allergic reactions to Olumiant or other JAK inhibitors.

Interactions

Olumiant may interact with other medications, including live vaccines and other biologic medications. Be sure to tell your doctor about all of the medications you are taking before starting Olumiant.

Contraindications

Olumiant is contraindicated in patients with a history of severe allergic reactions to Olumiant or other JAK inhibitors.

Overdose

There is no known overdose of Olumiant.

Side Effects

The most common side effects of Olumiant are upper respiratory tract infections, headache, diarrhea, nausea, fatigue, and injection site reactions.

More serious side effects of Olumiant include serious infections, blood clots, cancer, high cholesterol, high liver enzymes, low blood counts, lymphoma, heart problems, stomach problems, and stroke.

If you experience any side effects while taking Olumiant, be sure to tell your doctor.

Disclaimer

This information is not intended to be a substitute for professional medical advice. Always talk to your doctor about the risks and benefits of any medication before taking it.

Package

28 tablets of 2 mg, 98 tablets of 2 mg, 28 tablets of 4 mg, 98 tablets of 4 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Rukobia (fostemsavir) Online

(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: ViiV Healthcare USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Rukobia, known by its generic name Fostemsavir, is a prescription medication used in the treatment of HIV-1 infection in adults who have limited treatment options due to resistance, intolerance, or other factors. It is classified as an attachment inhibitor, a novel class of antiretroviral drugs that work differently from traditional HIV medications.

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Buy Adbry (tralokinumab-ldrm) Online

$1,283.00
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Leo Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Adbry (tralokinumab-ldrm) is a fully human monoclonal antibody that neutralizes the activity of interleukin-13 (IL-13), a cytokine that plays a key role in the pathogenesis of atopic dermatitis. Adbry is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older.

Buy Cabenuva (cabotegravir + rilpivirine) Online

From $3,894.54
(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: ViiV Healthcare MEDICINE APPROVED BY: Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Cabenuva is a combination medication used for the treatment of HIV-1 infection in adults who have already achieved viral suppression with a stable antiretroviral regimen. It is a novel therapy that offers a long-acting, injectable option for maintaining HIV suppression, offering potential benefits in terms of convenience and adherence.

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Zoryve (roflumilast) Online

$1,026.40
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.

Buy Vocabria (cabotegravir) Online

$647.13
(0 Reviews)
DISEASE INDICATIONS: HIV/AIDS MANUFACTURER: ViiV Healthcare USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Vocabria, known by its generic name Cabotegravir, is a prescription medication used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

Back to Top
Product has been added to your cart